Eli Lilly captures weight loss market share

3 months ago

Denita Sakova

"We have Eli Liy today. Now it's up about 2% but we saw much bigger gain in earlier trading. Uh once the market opened it jumped as much as 3.4%. Of course, with strong guidance raised for both their weight loss drug and diabetes drug, they're taking bigger market share in this competitive field. They now account for 58% of the market and outpaced expectations by nearly 1.3 billion. Mizuku is saying it's very clear that Eli Lely is winning the weight loss race. Obviously, now we're talking about more advanced drugs that could open a new leg in the competition."

The commentary highlights Eli Lilly's robust performance driven by raised guidance and expanding market share in weight loss and diabetes drugs, reinforcing its competitive edge.

Related Stocks